MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Design of the Remote Optimization Adjustment and Measurement for Deep Brain Stimulation (ROAM-DBS) Randomized Controlled Trial Using Decentralized Patient Monitoring

    T. Tomlinson, A. Gharabaghi, S. Groppa, L. Luo, H. Lu, M. Feldman, C. Luca, V. Marshall, A. Merola, L. Muñoz-Delgado, A. Schnitzler, L. Verhagen, B. Walter, C. Wu, S. Zauber, L. Zhang, B. Cheeran (Plano, USA)

    Objective: To describe the design of the ROAM-DBS trial which measures outcomes of remote programming using remote monitoring. Background: A third of Parkinson’s Disease (PD)…
  • 2022 International Congress

    ‘Top of the POPPS’ – how we set up an online support group for Partners of People with Parkinson’s.

    E. Edwards, S. Austin, J. Friend (Plymouth, United Kingdom)

    Objective: To provide useful peer and professional support for partners of people with Parkinson's (PWP)To be able to offer that support in a Covid safe…
  • 2022 International Congress

    A qualitative study exploring the treatment burden and capacity of people with Parkinson’s and their caregivers

    QY. Tan, H. Roberts, S. Fraser, K. Ibrahim (Southampton, United Kingdom)

    Objective: To explore experiences of treatment burden and capacity in Parkinson’s and identify potentially modifiable factors that can improve this Background: Treatment burden, the workload…
  • 2022 International Congress

    Lymphocyte count/neutrophil-to-lymphocyte ratio and mild cognitive impairment in Parkinson’s disease

    E. Contaldi, L. Magistrelli, S. Gallo, C. Comi (Novara, Italy)

    Objective: The present study aimed to elucidate whether i) lymphocyte count and neutrophil-to-lymphocyte ratio (NLR) can discriminate Parkinson's disease (PD) patients from healthy controls (HC);…
  • 2022 International Congress

    Developing zebrafish CRISPR/Cas9 knockout models of Parkinson’s Disease to identify novel therapeutic targets.

    J. García-Fernández, L. López-Blanch, M. Irimia, F. de Santis, J. Terriente (Badalona, Spain)

    Objective: Human patients present punctual mutations and/or small deletions in genes that have been associated with Parkinson’s disease, namely, park1, park2, park6, park7, and park8.…
  • 2022 International Congress

    Anthropometric Changes in Parkinson’s Disease: Canadian Longitudinal Study on Aging

    S. Zolfaghari, A. Pelletier, R. Postuma (Montreal, Canada)

    Objective: To explore the predictive role of anthropometric changes and development of Parkinson’s Disease (PD). Background: There is a tendency to lose weight in PD,…
  • 2022 International Congress

    Correlation between cognitive/emotional factors and postural control in patients with Parkinson’s disease

    A. Bitiati, C. de Oliveira, C. de Souza, A. Batista, R. Marquesini, A. Moreira-Neto, C. Batista, L. Teixeira, A. Pardini, D. Coelho (Santo André, Brazil)

    Objective: This study aims to find associations between executive function, anxiety, depression, and reactive and anticipatory postural control domains. Background: Cognition and emotional state are…
  • 2022 International Congress

    Genetic correlation and potential causal relationship between inflammatory bowel disease and Parkinson’s disease

    S. Grover, E. Wacker, A. Kumar-Sreelatha, A. Elbaz, R. Krüger, T. Gasser, D. Ellinghaus, M. Sharma (Tuebingen, Germany)

    Objective: The present study investigates shared genetic etiology between inflammatory bowel disease (IBD) and Parkinson’s disease (PD) using correlation and causality-based approaches. Background: The role…
  • 2022 International Congress

    Subgroup analyses by Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) of patients treated with levodopa inhalation powder 84mg or placebo to treat OFF symptoms in patients with Parkinson’s disease (PD)

    D. Grosset, P. Zhao, R. Marini, R. Cohen, B. Blank (Glasgow, United Kingdom)

    Objective: An analysis of the proportion of patients who turned ON after levodopa inhalation powder (CVT-301) 84mg treatment vs placebo, compared across subgroups of patients…
  • 2022 International Congress

    Clinical presentation of SNCA Duplication Parkinsonism in a Family Kindred

    K. Dent, M. Rochman, D. Kremens, J. Ratliff (Philadelphia, USA)

    Objective: To report phenotype variability in a family with SNCA duplication associated Parkinsonism. Background: Pathogenic variants in SNCA, the gene coding for α-synuclein, cause familial…
  • « Previous Page
  • 1
  • …
  • 318
  • 319
  • 320
  • 321
  • 322
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley